These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11799995)

  • 1. Single antibiotic therapy as effective as dual in treating patients hospitalized with community acquired pneumonia.
    Rollins G
    Rep Med Guidel Outcomes Res; 2000 Aug; 11(16):6-8. PubMed ID: 11799995
    [No Abstract]   [Full Text] [Related]  

  • 2. Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients?
    See S
    J Fam Pract; 2000 Oct; 49(10):883-4. PubMed ID: 11052155
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia.
    Paladino JA; Gudgel LD; Forrest A; Niederman MS
    Chest; 2002 Oct; 122(4):1271-9. PubMed ID: 12377852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
    Vergis EN; Indorf A; File TM; Phillips J; Bates J; Tan J; Sarosi GA; Grayston JT; Summersgill J; YU VL
    Arch Intern Med; 2000 May; 160(9):1294-300. PubMed ID: 10809032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
    Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
    Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community -acquired pneumonia in children.
    Aurangzeb B; Hameed A
    J Coll Physicians Surg Pak; 2003 Dec; 13(12):704-7. PubMed ID: 15569557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and therapy of Rhodococcus equi infection in the horse].
    Boswinkel M; Sloet van Oldruitenborgh-Oosterbaan MM
    Tijdschr Diergeneeskd; 2006 Sep; 131(17):602-11. PubMed ID: 16989420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
    Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
    Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials.
    Pitsouni E; Iavazzo C; Athanasiou S; Falagas ME
    Int J Antimicrob Agents; 2007 Sep; 30(3):213-21. PubMed ID: 17596917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis.
    Howard KB; Blumenschein K; Rapp RP
    Am J Health Syst Pharm; 1999 Aug; 56(15):1521-4. PubMed ID: 10478989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia.
    Najib MM; Stein GE; Goss TF
    Pharmacotherapy; 2000 Apr; 20(4):461-9. PubMed ID: 10772376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group.
    Plouffe J; Schwartz DB; Kolokathis A; Sherman BW; Arnow PM; Gezon JA; Suh B; Anzuetto A; Greenberg RN; Niederman M; Paladino JA; Ramirez JA; Inverso J; Knirsch CA
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1796-802. PubMed ID: 10858333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin versus comparative therapy for the treatment of community acquired pneumonia.
    Rahav G; Fidel J; Gibor Y; Shapiro M
    Int J Antimicrob Agents; 2004 Aug; 24(2):181-4. PubMed ID: 15288319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of oral gemifloxacin versus intravenous ceftriaxone followed by oral cefuroxime with/without a macrolide for the treatment of hospitalized patients with community-acquired pneumonia.
    Bhavnani SM; Ambrose PG
    Diagn Microbiol Infect Dis; 2008 Jan; 60(1):59-64. PubMed ID: 17889491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumonia: update on diagnosis and treatment.
    Gleckman RA
    Geriatrics; 1991 Feb; 46(2):49-50, 55-6. PubMed ID: 1991621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
    Martin M; Moore L; Quilici S; Decramer M; Simoens S
    Curr Med Res Opin; 2008 Mar; 24(3):737-51. PubMed ID: 18230196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance in community-acquired pneumonia.
    Woodhead M
    Br J Hosp Med; 1992 May 6-19; 47(9):684-7. PubMed ID: 1617342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].
    Schouten JA; Prins JM; Bonten M; Degener JE; Janknegt R; Hollander JM; Jonkers R; Wijnands W; Verheij T; Sachs A; Kullberg BJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2495-500. PubMed ID: 16304886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.